Rocket Lab Joins Nasdaq-100: A $90 Million Defense Win and a 27% Monthly Slide Frame the New Reality
Published on 06/22/2026 at 18:06 | Redaktion boerse-global.de
The day Rocket Lab earned a spot in the Nasdaq-100, a milestone that should have been a catalyst, the stock instead tumbled 8% to $98.50. The index inclusion, effective from the June 2026 quarterly rebalancing alongside Astera Labs, CoreWeave, Nebius Group and Teradyne, had evidently been priced in by a market now fixated on the company’s stratospheric valuation. With a market capitalisation of nearly $65 billion, Rocket Lab trades at roughly 81 times its annualised first-quarter revenue — a multiple that demands nothing less than flawless execution.
That execution narrative received a distinct boost in the form of a $90 million contract with the U.S. Space Force’s Space Systems Command. Rocket Lab will build, integrate, and operate two geostationary satellites carrying Heimdall space?surveillance payloads. It marks the company’s first satellite programme for geostationary orbit and a tangible demonstration of its expanding role in national security. The order books, already at a record $2.2 billion, were further thickened by 31 new contracts for the Electron and HASTE rockets and five booked flights for the larger Neutron launcher, bringing the total manifest to over 70 missions.
Yet the financials tell a story of heavy investment weighing on the bottom line. First?quarter revenue surged 63.5% to $200.3 million, but the net loss stood at $45 million — an improvement from $61 million a year earlier, but still a drag. The GAAP gross margin came in at 38.2%. For the current quarter, management guides revenue between $225 million and $240 million, with gross margin softening to 33?35% and an operating loss of up to $26 million. The margin compression underscores the cost of scaling infrastructure and research spending.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The market’s reaction has been brutal over the short term. Over seven days the stock has lost nearly 10%, and over 30 days the decline has deepened to 27%. That puts the share price 35% below its 52?week high of $151.00, reached only at the end of May. On a year?to?date basis, however, the picture remains positive with a gain of roughly 30%, and over twelve months the equity has more than tripled. The contradiction is plain: the growth story is intact, but the valuation is being recalibrated.
Technically, the stock now trades below its 50?day moving average of $104.54, with a relative strength index of 42.3 signalling weakness short of oversold territory. The annualised 30?day volatility of over 100% reflects how swiftly sentiment can turn. Passively managed funds tracking the Nasdaq?100 will add structurally to the shareholder base over time, but immediate buying pressure alone could not prevent profit?taking.
For Rocket Lab to justify its premium — and for the index inclusion to become more than a fleeting milestone — the market requires evidence of rising margins, a steady conversion of the $2.2 billion backlog into revenue, and a profitable expansion trajectory. The next quarterly report will be the first real test of whether this high?flying space stock can deliver the proof investors are demanding.
Ad
Rocket Lab USA Stock: New Analysis - 22 June
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
